UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811-03595
Name of Fund: Merrill Lynch Healthcare Fund, Inc.
Fund Address: P.O. Box 9011
Princeton, NJ 08543-9011
Name and address of agent for service:
Terry K. Glenn, President Merrill Lynch Healthcare Fund,
Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536.
Mailing address: P.O. Box 9011, Princeton, NJ, 08543-9011
Registrant's telephone number, including area code: (609) 282-2800
Date of fiscal year end: 4/30/2005
Date of reporting period: 07/01/03 - 06/30/04
Item 1 - Proxy Voting Record
The information contained herein discloses the following information
for each matter relating to a portfolio security considered at any
shareholder meeting held during the period covered by the report and
with respect to which the registrant was entitled to vote:
(a) The name of the issuer of the portfolio security;
(b) The exchange ticker symbol of the portfolio security;
(c) The Council on Uniform Securities Identification Procedures
("CUSIP") number for the portfolio security;
(d) The shareholder meeting date;
(e) A brief identification of the matter voted on;
(f) Whether the matter was proposed by the issuer or by a security
holder;
(g) Whether the registrant cast its vote on the matter;
(h) How the registrant cast its vote; and
(i) Whether the registrant cast its vote for or against management.
******************************* FORM N-Px REPORT *******************************
ICA File Number: 811-03595
Reporting Period: 07/01/2003 - 06/30/2004
Merrill Lynch Healthcare Fund, Inc.
===================== MERRILL LYNCH HEALTHCARE FUND, INC. ======================
ABGENIX, INC.
Ticker: ABGX Security ID: 00339B107
Meeting Date: JUN 7, 2004 Meeting Type: Annual
Record Date: APR 12, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director R. Scott Greer For For Management
1.2 Elect Director M. Kathleen Behrens, For For Management
Ph.D.
1.3 Elect Director Raju S. Kucherlapati, For For Management
Ph.D.
1.4 Elect Director Kenneth B. Lee, Jr. For For Management
1.5 Elect Director Mark B. Logan For For Management
1.6 Elect Director Thomas G. Wiggans For For Management
1.7 Elect Director Raymond M. Withy, Ph.D. For For Management
- --------------------------------------------------------------------------------
AMGEN, INC.
Ticker: AMGN Security ID: 031162100
Meeting Date: MAY 13, 2004 Meeting Type: Annual
Record Date: MAR 19, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Frank J. Biondi, Jr. For For Management
1.2 Elect Director Jerry D. Choate For For Management
1.3 Elect Director Frank C. Herringer For For Management
1.4 Elect Director Gilbert S. Omenn For For Management
2 Ratify Auditors For For Management
3 Prepare Glass Ceiling Report Against Against Shareholder
4 Expense Stock Options Against For Shareholder
- --------------------------------------------------------------------------------
ANTHEM INC.
Ticker: ATH Security ID: 03674B104
Meeting Date: JUN 28, 2004 Meeting Type: Special
Record Date: MAY 10, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1 Issue Shares in Connection with an For For Management
Acquisition
2 Change Company Name For For Management
- --------------------------------------------------------------------------------
ANTHEM INC.
Ticker: ATH Security ID: 03674B104
Meeting Date: MAY 17, 2004 Meeting Type: Annual
Record Date: MAR 19, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Victor S. Liss For For Management
1.2 Elect Director James W. McDowell, Jr. For For Management
1.3 Elect Director George A. Schaefer, Jr. For For Management
1.4 Elect Director Jackie M. Ward For For Management
- --------------------------------------------------------------------------------
ARK THERAPEUTICS GROUP PLC, LONDON
Ticker: Security ID: GB0034251727
Meeting Date: JUL 5, 2004 Meeting Type: Annual
Record Date:
# Proposal Mgt Rec Vote Cast Sponsor
1 Accept Financial Statements and Statutory For For Management
Reports
2 Re-elect Dennis Turner as Director For For Management
3 Re-elect Nigel Parker as Director For For Management
4 Elect David Prince as Director For For Management
5 Elect Wolfgang Plischke as Director For For Management
6 Re-elect Mark Richmond as Director For For Management
7 Re-appoint Deloitte and Touche LLP as For For Management
Auditors and Authorise Board to Fix
Remuneration of Auditors
8 Authorise Issuance of Equity or For For Management
Equity-Linked Securities with Pre-emptive
Rights up to Aggregate Nominal Amount of
GBP 378,993
9 Authorise Issuance of Equity or For Against Management
Equity-Linked Securities without
Pre-emptive Rights up to Aggregate
Nominal Amount of GBP 63,135
- --------------------------------------------------------------------------------
BARR PHARMACEUTICALS INC
Ticker: BRL Security ID: 068306109
Meeting Date: OCT 23, 2003 Meeting Type: Annual
Record Date: SEP 2, 2003
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Bruce L. Downey For Withhold Management
1.2 Elect Director Paul M. Bisaro For Withhold Management
1.3 Elect Director Carole S. Ben-Maimon For Withhold Management
1.4 Elect Director George P. Stephan For For Management
1.5 Elect Director Jack M. Kay For For Management
1.6 Elect Director Harold N. Chefitz For For Management
1.7 Elect Director Richard R. Frankovic For For Management
1.8 Elect Director Peter R. Seaver For For Management
1.9 Elect Director James S. Gilmore, III For For Management
2 Change State of Incorporation from New For For Management
York to Delaware
3 Increase Authorized Common Stock For For Management
- --------------------------------------------------------------------------------
BOSTON SCIENTIFIC CORP.
Ticker: BSX Security ID: 101137107
Meeting Date: MAY 11, 2004 Meeting Type: Annual
Record Date: MAR 19, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Ursula M. Burns For For Management
1.2 Elect Director Marye Anne Fox For For Management
1.3 Elect Director N.J. Nicholas, Jr. For For Management
1.4 Elect Director John E. Pepper For For Management
2 Ratify Auditors For For Management
- --------------------------------------------------------------------------------
BOSTON SCIENTIFIC CORP.
Ticker: BSX Security ID: 101137107
Meeting Date: OCT 6, 2003 Meeting Type: Special
Record Date: AUG 27, 2003
# Proposal Mgt Rec Vote Cast Sponsor
1 Increase Authorized Common Stock For For Management
- --------------------------------------------------------------------------------
CADILA HEALTHCARE LTD
Ticker: Security ID: INE010B01019
Meeting Date: JUL 20, 2004 Meeting Type: Annual
Record Date:
# Proposal Mgt Rec Vote Cast Sponsor
1 Accept Financial Statements and Statutory For For Management
Reports
2 Approve Dividends of INR 6 Per Share For For Management
3 Reappoint M.A. Patel as Director For For Management
4 Reappoint S.P. Patel as Director For For Management
5 Approve R.R. Patel as Auditors and For For Management
Authorize Board to Fix Their Remuneration
- --------------------------------------------------------------------------------
CELL GENESYS, INC.
Ticker: CEGE Security ID: 150921104
Meeting Date: JUN 10, 2004 Meeting Type: Annual
Record Date: APR 23, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Stephen A. Sherwin, M.D. For For Management
1.2 Elect Director David W. Carter For For Management
1.3 Elect Director Nancy M. Crowell For For Management
1.4 Elect Director James M. Gower For For Management
1.5 Elect Director John T. Potts, Jr., M.D. For For Management
1.6 Elect Director Thomas E. Shenk, Ph.D. For For Management
1.7 Elect Director Eugene L. Step For For Management
1.8 Elect Director Inder M. Verma, Ph.D. For For Management
1.9 Elect Director Dennis L. Winger For For Management
2 Approve Stock Option Plan For For Management
3 Ratify Auditors For For Management
4 Other Business For Against Management
- --------------------------------------------------------------------------------
CELL THERAPEUTICS, INC.
Ticker: CTIC Security ID: 150934107
Meeting Date: OCT 23, 2003 Meeting Type: Special
Record Date: SEP 12, 2003
# Proposal Mgt Rec Vote Cast Sponsor
1 Approve Merger Agreement For For Management
- --------------------------------------------------------------------------------
CEPHALON, INC.
Ticker: CEPH Security ID: 156708109
Meeting Date: MAY 13, 2004 Meeting Type: Annual
Record Date: MAR 18, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Frank Baldino, Jr., Ph.D. For For Management
1.2 Elect Director William P. Egan For For Management
1.3 Elect Director Robert J. Feeney, Ph.D. For For Management
1.4 Elect Director Martyn D. Greenacre For For Management
1.5 Elect Director Charles A. Sanders, M.D. For For Management
1.6 Elect Director Gail R. Wilensky, Ph.D. For For Management
1.7 Elect Director Dennis L. Winger For For Management
1.8 Elect Director Horst Witzel, Dr.-Ing. For For Management
2 Amend Omnibus Stock Plan For For Management
- --------------------------------------------------------------------------------
CERNER CORP.
Ticker: CERN Security ID: 156782104
Meeting Date: MAY 28, 2004 Meeting Type: Annual
Record Date: APR 2, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Gerald E. Bisbee, Jr., For For Management
Ph.D.
1.2 Elect Director Michael E. Herman For For Management
1.3 Elect Director Nancy-Ann DeParle For For Management
2 Approve Omnibus Stock Plan For Against Management
3 Ratify Auditors For For Management
- --------------------------------------------------------------------------------
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Ticker: CRL Security ID: 159864107
Meeting Date: MAY 12, 2004 Meeting Type: Annual
Record Date: MAR 15, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director James C. Foster For For Management
1.2 Elect Director Robert Cawthorn For For Management
1.3 Elect Director Stephen D. Chubb For For Management
1.4 Elect Director George E. Massaro For For Management
1.5 Elect Director George M. Milne For For Management
1.6 Elect Director Douglas E. Rogers For For Management
1.7 Elect Director Samuel O. Thier For For Management
1.8 Elect Director William H. Waltrip For For Management
2 Ratify Auditors For For Management
- --------------------------------------------------------------------------------
CIPLA LIMITED
Ticker: Security ID: INE059A01018
Meeting Date: APR 21, 2004 Meeting Type: Special
Record Date:
# Proposal Mgt Rec Vote Cast Sponsor
1 Approve Issuance of 1,700 Shares for For For Management
Private Placement
2 Approve 5-for-1 Stock Split For For Management
3 Amend Memorandum of Association Re: For For Management
5-for-1 Stock Split
4 Amend Articles of Association Re: 5-for-1 For For Management
Stock Split
- --------------------------------------------------------------------------------
CIPLA LIMITED
Ticker: Security ID: INE059A01018
Meeting Date: APR 21, 2004 Meeting Type: Court
Record Date:
# Proposal Mgt Rec Vote Cast Sponsor
1 Approve Scheme of Arrangement with For For Management
Oncocare India Private Ltd., Medule
Pharma Private Ltd., Medex Specialities
Private Ltd., Lancet Pharma Private Ltd.,
Inhaled Technologies Private Ltd. and
Nebumed Pharma Private Ltd.
- --------------------------------------------------------------------------------
COMMUNITY HEALTH SYSTEMS, INC.
Ticker: CYH Security ID: 203668108
Meeting Date: MAY 25, 2004 Meeting Type: Annual
Record Date: MAR 31, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director W. Larry Cash For For Management
1.2 Elect Director J. Anthony Forstmann For For Management
1.3 Elect Director Harvey Klein, M.D. For For Management
1.4 Elect Director H. Mitchell Watson, Jr. For For Management
2 Approve Executive Incentive Bonus Plan For For Management
3 Ratify Auditors For For Management
4 Separate Chairman and CEO Positions Against Against Shareholder
- --------------------------------------------------------------------------------
CONCEPTUS, INC.
Ticker: CPTS Security ID: 206016107
Meeting Date: JUN 1, 2004 Meeting Type: Annual
Record Date: APR 19, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Mark M. Sieczkarek For For Management
1.2 Elect Director Thomas F. Bonadio For For Management
2 Ratify Auditors For For Management
3 Amend Omnibus Stock Plan For For Management
4 Amend Omnibus Stock Plan For For Management
5 Amend Employee Stock Purchase Plan For For Management
- --------------------------------------------------------------------------------
CYTYC CORPORATION
Ticker: CYTC Security ID: 232946103
Meeting Date: MAY 26, 2004 Meeting Type: Annual
Record Date: APR 5, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Walter E. Boomer For For Management
1.2 Elect Director Daniel J. Levangie For For Management
1.3 Elect Director Joseph B. Martin, M.D., For For Management
Ph.D.
2 Approve Omnibus Stock Plan For For Management
3 Approve Employee Stock Purchase Plan For For Management
4 Ratify Auditors For For Management
- --------------------------------------------------------------------------------
DOV PHARMACEUTICAL, INC.
Ticker: DOVP Security ID: 259858108
Meeting Date: MAY 24, 2004 Meeting Type: Annual
Record Date: APR 23, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Dr. Bernard Beer For For Management
1.2 Elect Director Dr. Zola Horovitz For For Management
1.3 Elect Director Ms. Theresa Bischoff For For Management
2 Amend Omnibus Stock Plan For For Management
3 Ratify Auditors For For Management
- --------------------------------------------------------------------------------
FLAMEL TECHNOLOGIES S.A.
Ticker: FLML Security ID: 338488109
Meeting Date: JUN 22, 2004 Meeting Type: Annual
Record Date: MAY 14, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1 THE SHAREHOLDERS MEETING, AFTER HAVING For Did Not Management
TAKEN COGNIZANCE OF THE FINANCIAL Vote
STATEMENTS FOR THE FINANCIAL YEAR ENDED
ON 2003
2 THE SHAREHOLDERS MEETING DECIDES TO For Did Not Management
ALLOCATE THE PROFITS FOR THE FINANCIAL Vote
YEAR ENDED ON DECEMBER 31, 2003
3 THE SHAREHOLDERS MEETING, ACKNOWLEDGING For Did Not Management
THAT THE TERM OF THE DIRECTOR S OFFICE OF Vote
GERARD SOULA EXPIRES AT THIS MEETING
4 THE SHAREHOLDERS MEETING, ACKNOWLEDGING For Did Not Management
THAT THE TERM OF THE DIRECTOR S OFFICE OF Vote
STEVE WILLARD EXPIRES AT THIS MEETING
5 THE SHAREHOLDERS MEETING, ACKNOWLEDGING For Did Not Management
THAT THE TERM OF THE DIRECTOR S OFFICE OF Vote
RAUL CESAN EXPIRES AT THIS MEETING
6 THE SHAREHOLDERS MEETING, ACKNOWLEDGING For Did Not Management
THAT THE TERM OF THE DIRECTOR S OFFICE OF Vote
WILLIAM DEARSTYNE EXPIRES AT THIS MEETING
7 THE SHAREHOLDERS MEETING, ACKNOWLEDGING For Did Not Management
THAT THE TERM OF THE DIRECTOR S OFFICE OF Vote
MICHEL GRECO EXPIRES AT THIS MEETING
8 THE SHAREHOLDERS MEETING, ACKNOWLEDGING For Did Not Management
THAT THE TERM OF THE DIRECTOR S OFFICE OF Vote
JEAN NOEL TREILLES EXPIRES AT THIS
MEETING
9 IN ACCORDANCE WITH SECTION 223 QUATER OF For Did Not Management
THE GENERAL TAX CODE WERE INCURRED DURING Vote
THE FINANCIAL YEAR
10 THE STATUTORY AUDITOR S SPECIAL REPORT For Did Not Management
REGARDING THE AGREEMENTS REFERRED TO IN Vote
SECTIONS L. 225-38
11 THE STATUTORY AUDITOR S SPECIAL REPORT For Did Not Management
REGARDING THE AGREEMENTS REFERRED TO IN Vote
SECTIONS L. 225-38
12 THE BOARD OF DIRECTORS REPORT AND OF THE For Did Not Management
STATUTORY AUDITOR S SPECIAL REPORT THE Vote
GENERAL SHAREHOLDERS MEETING
13 THE PRECEDING RESOLUTION AND HAVING THE For Did Not Management
BOARD OF DIRECTORS REPORT AND OF THE Vote
STATUTORY AUDITOR S SPECIAL REPORT
14 THE ADOPTION OF THE TWO PRECEDING For Did Not Management
RESOLUTIONS Vote
15 THE SHAREHOLDERS MEETING GRANTS A POWER For Did Not Management
OF ATTORNEY Vote
- --------------------------------------------------------------------------------
GENTA INCORPORATED
Ticker: GNTA Security ID: 37245M207
Meeting Date: JUN 23, 2004 Meeting Type: Annual
Record Date: APR 30, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Raymond P. Warrell, Jr., For For Management
M.D.
1.2 Elect Director Jerome E. Groopman, M.D. For For Management
1.3 Elect Director Betsy McCaughey, Ph.D. For For Management
1.4 Elect Director Peter T. Tattle For For Management
1.5 Elect Director Daniel D. Von Hoff, M.D. For For Management
1.6 Elect Director Harlan J. Wakoff For For Management
1.7 Elect Director Douglas G. Watson For For Management
1.8 Elect Director Michael S. Weiss For For Management
2 Increase Authorized Common Stock For For Management
3 Amend Omnibus Stock Plan For For Management
4 Amend Non-Employee Director Stock Option For For Management
Plan
5 Ratify Auditors For For Management
- --------------------------------------------------------------------------------
GILEAD SCIENCES, INC.
Ticker: GILD Security ID: 375558103
Meeting Date: MAY 25, 2004 Meeting Type: Annual
Record Date: APR 5, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Paul Berg For For Management
1.2 Elect Director Etienne F. Davignon For For Management
1.3 Elect Director James M. Denny For For Management
1.4 Elect Director John C. Martin For For Management
1.5 Elect Director Gordon E. Moore For For Management
1.6 Elect Director Nicholas G. Moore For For Management
1.7 Elect Director George P. Shultz For For Management
1.8 Elect Director Gayle E. Wilson For For Management
2 Ratify Auditors For For Management
3 Approve Omnibus Stock Plan For For Management
4 Increase Authorized Common Stock For For Management
- --------------------------------------------------------------------------------
HCA, INC.
Ticker: HCA Security ID: 404119109
Meeting Date: MAY 27, 2004 Meeting Type: Annual
Record Date: APR 1, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director C. Michael Armstrong For For Management
1.2 Elect Director Magdalena H. Averhoff, For For Management
M.D.
1.3 Elect Director Jack O. Bovender, Jr. For For Management
1.4 Elect Director Richard M. Bracken For For Management
1.5 Elect Director Martin Feldstein For For Management
1.6 Elect Director Thomas F. Frist, Jr., For For Management
M.D.
1.7 Elect Director Frederick W. Gluck For For Management
1.8 Elect Director Glenda A. Hatchett For For Management
1.9 Elect Director Charles O. Holliday, Jr. For For Management
1.10 Elect Director T. Michael Long For For Management
1.11 Elect Director John H. McArthur For For Management
1.12 Elect Director Kent C. Nelson For For Management
1.13 Elect Director Frank S. Royal, M.D. For For Management
1.14 Elect Director Harold T. Shapiro For For Management
2 Ratify Auditors For For Management
3 Amend Management Stock Purchase Plan For For Management
- --------------------------------------------------------------------------------
HENRY SCHEIN, INC.
Ticker: HSIC Security ID: 806407102
Meeting Date: MAY 25, 2004 Meeting Type: Annual
Record Date: APR 15, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Stanley M. Bergman For For Management
1.2 Elect Director Gerald A. Benjamin For For Management
1.3 Elect Director James P. Breslawski For For Management
1.4 Elect Director Mark E. Mlotek For For Management
1.5 Elect Director Steven Paladino For For Management
1.6 Elect Director Barry J. Alperin For For Management
1.7 Elect Director Pamela Joseph For Withhold Management
1.8 Elect Director Donald J. Kabat For For Management
1.9 Elect Director Marvin H. Schein For For Management
1.10 Elect Director Irving Shafran For For Management
1.11 Elect Director Philip A. Laskawy For For Management
1.12 Elect Director Norman S. Matthews For For Management
1.13 Elect Director Louis W. Sullivan For For Management
1.14 Elect Director Margaret A. Hamburg For For Management
2 Amend Stock Option Plan For For Management
3 Amend Non-Employee Director Omnibus Stock For For Management
Plan
4 Approve Employee Stock Purchase Plan For For Management
5 Ratify Auditors For For Management
- --------------------------------------------------------------------------------
ICOS CORP.
Ticker: ICOS Security ID: 449295104
Meeting Date: MAY 14, 2004 Meeting Type: Annual
Record Date: MAR 17, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Paul N. Clark For For Management
1.2 Elect Director Vaughn D. Bryson For For Management
1.3 Elect Director William H. Gates III For For Management
1.4 Elect Director Robert W. Pangia For For Management
2 Ratify Auditors For For Management
3 Review/Limit Executive Compensation Against Against Shareholder
- --------------------------------------------------------------------------------
IMCLONE SYSTEMS INC.
Ticker: IMCL Security ID: 45245W109
Meeting Date: JUN 17, 2004 Meeting Type: Annual
Record Date: APR 20, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Andrew G. Bodnar For For Management
1.2 Elect Director William W. Crouse For For Management
1.3 Elect Director Vincent T. Devita, Jr. For For Management
1.4 Elect Director John A. Fazio For For Management
1.5 Elect Director Joseph L. Fischer For For Management
1.6 Elect Director David M. Kies For For Management
1.7 Elect Director Daniel S. Lynch For For Management
1.8 Elect Director William R. Miller For For Management
1.9 Elect Director David Sidransky For For Management
2 Ratify Auditors For For Management
- --------------------------------------------------------------------------------
K-V PHARMACEUTICAL CO.
Ticker: KV.B Security ID: 482740206
Meeting Date: AUG 28, 2003 Meeting Type: Annual
Record Date: JUL 1, 2003
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Victor M. Hermelin For Withhold Management
1.2 Elect Director Alan G. Johnson For Withhold Management
- --------------------------------------------------------------------------------
KOSAN BIOSCIENCES INC.
Ticker: KOSN Security ID: 50064W107
Meeting Date: MAY 27, 2004 Meeting Type: Annual
Record Date: APR 1, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Chaitan S. Khosla, Ph.D. For For Management
1.2 Elect Director Charles J. Homcy, M.D. For For Management
- --------------------------------------------------------------------------------
LA JOLLA PHARMACEUTICAL CO.
Ticker: LJPC Security ID: 503459109
Meeting Date: MAY 21, 2004 Meeting Type: Annual
Record Date: APR 2, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Stephen M. Martin For For Management
1.2 Elect Director William R. Ringo For For Management
1.3 Elect Director Robert A. Fildes For For Management
2 Approve Omnibus Stock Plan For For Management
3 Amend Employee Stock Purchase Plan For For Management
4 Ratify Auditors For For Management
- --------------------------------------------------------------------------------
LEXICON GENETICS, INC.
Ticker: LEXG Security ID: 528872104
Meeting Date: MAY 19, 2004 Meeting Type: Annual
Record Date: MAR 30, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Robert J. Lefkowitz, M.D. For For Management
1.2 Elect Director Alan S. Nies, M.D. For For Management
2 Approve Omnibus Stock Plan For For Management
3 Ratify Auditors For For Management
- --------------------------------------------------------------------------------
MEDAREX, INC.
Ticker: MEDX Security ID: 583916101
Meeting Date: MAY 19, 2004 Meeting Type: Annual
Record Date: MAR 22, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Mr. Irwin Lerner For For Management
1.2 Elect Director Dr. Julius A. Vida For For Management
2 Ratify Auditors For For Management
- --------------------------------------------------------------------------------
MEDICINES COMPANY (THE)
Ticker: MDCO Security ID: 584688105
Meeting Date: MAY 27, 2004 Meeting Type: Annual
Record Date: APR 16, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director William W. Crouse For For Management
1.2 Elect Director T. Scott Johnson For For Management
1.3 Elect Director David M. Stack For For Management
2 Ratify Auditors For For Management
3 Approve Omnibus Stock Plan For For Management
- --------------------------------------------------------------------------------
NABI BIOPHARMACEUTICALS
Ticker: NABI Security ID: 629519109
Meeting Date: MAY 14, 2004 Meeting Type: Annual
Record Date: MAR 30, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director David L. Castaldi For For Management
1.2 Elect Director Geoffrey F. Cox, Ph.D. For For Management
1.3 Elect Director George W. Ebright For For Management
1.4 Elect Director Richard A. Harvey, Jr. For For Management
1.5 Elect Director Linda Jenckes For For Management
1.6 Elect Director Thomas H. McLain For For Management
1.7 Elect Director Stephen G. Sudovar For For Management
2 Increase Authorized Common Stock For For Management
3 Amend Omnibus Stock Plan For Against Management
4 Approve Non-Employee Director Stock For For Management
Option Plan
- --------------------------------------------------------------------------------
NEUROCRINE BIOSCIENCES, INC.
Ticker: NBIX Security ID: 64125C109
Meeting Date: MAY 26, 2004 Meeting Type: Annual
Record Date: APR 1, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Richard F. Pops For For Management
1.2 Elect Director Stephen A. Sherwin, M.D. For For Management
2 Ratify Auditors For For Management
3 Amend Omnibus Stock Plan For For Management
- --------------------------------------------------------------------------------
NOVARTIS AG
Ticker: NVS Security ID: CH0012005267
Meeting Date: FEB 24, 2004 Meeting Type: Annual
Record Date: FEB 4, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1 Accept Financial Statements and Statutory For Did Not Management
Reports Vote
2 Approve Discharge of the Board and Senior For Did Not Management
Management Vote
3 Approve Allocation of Income and For Did Not Management
Dividends of CHF 1.00 per Share Vote
4 Approve Transfer of CHF 360.9 Million For Did Not Management
from General Reserves to Free Reserves Vote
5 Approve CHF 12.1 Million Reduction in For Did Not Management
Share Capital via Share Cancellation Vote
6 Authorize Repurchase of up to Ten Percent For Did Not Management
of Issued Share Capital Vote
7 Amend Articles Re: Reduce Board Terms For Did Not Management
from Four to Three Years Vote
8.1 Approve Resignation of Walter Frehner and For Did Not Management
Heini Lippuner Vote
8.2 Elect Helmut Sihler, Hans-Joerg Rudloff For Did Not Management
and Daniel Vasella as Directors Vote
9 Ratify PricewaterhouseCoopers AG as For Did Not Management
Auditors Vote
- --------------------------------------------------------------------------------
QLT INC.
Ticker: QLT Security ID: 746927102
Meeting Date: MAY 26, 2004 Meeting Type: Annual
Record Date: APR 13, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1 Approve Deloitte & Touche LLP as Auditors For For Management
and Authorize Board to Fix Remuneration
of Auditors
2 Fix Number of Directors at Eight For For Management
3.1 Elect E. Duff Scott as a Director For For Management
3.2 Elect Paul J. Hastings as a Director For For Management
3.3 Elect Julia G. Levy as a Director For For Management
3.4 Elect C. Boyd Clarke as a Director For For Management
3.5 Elect Peter A. Crossgrove as a Director For For Management
3.6 Elect Ronald D. Henriksen as a Director For For Management
3.7 Elect Alan C. Mendelson as a Director For For Management
3.8 Elect L. Jack Wood as a Director For For Management
- --------------------------------------------------------------------------------
RANBAXY LABORATORIES
Ticker: Security ID: INE015A01010
Meeting Date: JUN 25, 2004 Meeting Type: Annual
Record Date:
# Proposal Mgt Rec Vote Cast Sponsor
1 Accept Financial Statements and Statutory For For Management
Reports
2 Approve Dividends of INR 17 Per Share For For Management
3 Reappoint T. Khanna as Director For For Management
4 Reappoint V.B. Ram as Director For For Management
5 Reappoint V. Mehra as Director For For Management
6 Approve Walker, Chandiok & Co as Auditors For For Management
and Authorize Board to Fix Their
Remuneration
7 Appoint V.K. Kaul as Director For For Management
8 Appoint G. Das as Director For For Management
9 Appoint M.M. Singh as Director For For Management
10 Approve Appointment and Remuneration of For For Management
M.M. Singh, Executive Director
11 Approve Appointment and Remuneration of For For Management
B.W. Tempest, Executive Director
12 Approve Commission Remuneration of For For Management
Non-executive Directors
- --------------------------------------------------------------------------------
SANOFI-SYNTHELABO (FORMERLY SANOFI)
Ticker: Security ID: FR0000120578
Meeting Date: JUN 23, 2004 Meeting Type: Annual/Special
Record Date:
# Proposal Mgt Rec Vote Cast Sponsor
1 Approve Financial Statements and For Did Not Management
Statutory Reports Vote
2 Accept Consolidated Financial Statements For Did Not Management
and Statutory Reports Vote
3 Approve Allocation of Income and For Did Not Management
Dividends of EUR 1.53 per Share Vote
4 Approve Special Auditors' Report For Did Not Management
Regarding Related-Party Transactions Vote
5 Authorize Repurchase of Up to Ten Percent For Did Not Management
of Issued Share Capital Vote
6 Authorize Issuance of Bonds/Debentures in For Did Not Management
the Aggregate Value of EUR 7 Billion Vote
7 Authorize Issuance of Equity or For Did Not Management
Equity-Linked Securities with Preemptive Vote
Rights up to Aggregate Nominal Amount of
EUR 750 Million; Set Global Limit for
Capital Increase to Result from Issuance
Requests in Items 7-10 at EUR 1.25
Billion
8 Authorize Issuance of Equity or For Did Not Management
Equity-Linked Securities without Vote
Preemptive Rights up to Aggregate Nominal
Amount of EUR 750 Million
9 Allow Board to Issue Shares in the Event For Did Not Management
of a Public Tender Offer or Share Vote
Exchange Offer
10 Authorize Capitalization of Reserves of For Did Not Management
Up to EUR 500 Million for Bonus Issue or Vote
Increase in Par Value
11 Approve Capital Increase Reserved for For Did Not Management
Employees Participating in Vote
Savings-Related Share Purchase Plan
12 Approve Stock Option Plan Grants For Did Not Management
Vote
13 Approve Reduction in Share Capital via For Did Not Management
Cancellation of Repurchased Shares Vote
14 Authorize Capital Increase of Up to EUR For Did Not Management
1.429 Billion for Aventis Exchange Offer Vote
15 Change Company Name to Sanofi-Aventis For Did Not Management
Vote
16 Amend Articles of Association to Reduce For Did Not Management
Term of Board Members from Five to Four Vote
Years
17 Amend Articles to Reflect 2003 Legal For Did Not Management
Changes Re: Powers of the Chairman Vote
18 Reelect Jean-Francois Dehecq as Director For Did Not Management
(Representing Sanofi-Synthelabo) Vote
19 Reelect Rene Barbier de la Serre as For Did Not Management
Director (Representing Sanofi-Synthelabo) Vote
20 Reelect Robert Castaigne as Director For Did Not Management
(Representing Sanofi-Synthelabo) Vote
21 Reelect Thierry Desmarest as Director For Did Not Management
(Representing Sanofi-Synthelabo) Vote
22 Reelect Lindsay Owen-Jones as Director For Did Not Management
(Representing Sanofi-Synthelabo) Vote
23 Reelect Bruno Weymuller as Director For Did Not Management
(Representing Sanofi-Synthelabo) Vote
24 Confirm Appointment of Lord Douro as For Did Not Management
Director (Representing Sanofi-Synthelabo) Vote
25 Confirm Appointment of Gerard Van Kemmel For Did Not Management
as Director (Representing Vote
Sanofi-Synthelabo)
26 Elect Christian Mulliez as Director For Did Not Management
(Representing Sanofi-Synthelabo) Vote
27 Elect Jean-Marc Bruel as Director For Did Not Management
(Representing Aventis) Vote
28 Elect Jurgen Dormann as Director For Did Not Management
(Representing Aventis) Vote
29 Elect Jean-Rene Fourtou as Director For Did Not Management
(Representing Aventis) Vote
30 Elect Serge Kampf as Director For Did Not Management
(Representing Aventis) Vote
31 Elect Igor Landau as Director For Did Not Management
(Representing Aventis) Vote
32 Elect Hubert Markl as Director For Did Not Management
(Representing Aventis) Vote
33 Elect Klaus Pohle as Director For Did Not Management
(Representing Aventis) Vote
34 Elect Hermann Scholl as Director For Did Not Management
(Representing Aventis) Vote
35 Confirm End of Term of Permanent For Did Not Management
Representative of Elf Aquitaine, L'Oreal, Vote
Pierre Castres Saint-Martin,
Pierre-Gilles de Gennes, and Herve Guerin
as Directors
36 Approve Remuneration of Directors in the For Did Not Management
Aggregate Amount of Up to EUR 1 Million Vote
37 Authorize Filing of Required For Did Not Management
Documents/Other Formalities Vote
- --------------------------------------------------------------------------------
SKYEPHARMA PLC
Ticker: Security ID: GB0008123571
Meeting Date: JUN 23, 2004 Meeting Type: Annual
Record Date:
# Proposal Mgt Rec Vote Cast Sponsor
1 Accept Financial Statements and Statutory For For Management
Reports
2.1 Approve Remuneration Report For For Management
2.2 Approve the Renumeration Committee's For For Management
Policy for Executive Renumeration for
2004
2.3 Approve the SkyePharma PLC Deferred Share For For Management
Bonus Plan
2.4 Approve the Operation of the Long-Term For For Management
Incentive Element of the SkyePharma PLC
Deferred Share Bonus Plan
3 Re-appoint PricewaterhouseCoopers LLP as For For Management
Auditors and Authorise Board to Fix
Remuneration of Auditors
4.1 Re-elect Ian Gowrie-Smith as Director For For Management
4.2 Re-elect Donald Nicholson as Director For For Management
4.3 Re-elect David Ebsworth as Director For For Management
4.4 Re-elect Sir Michael Beavis as Director For For Management
4.5 Re-elect Keith Mansford as Director For For Management
5 Authorise Issuance of Equity or For For Management
Equity-Linked Securities with Pre-emptive
Rights up to Aggregate Nominal Amount of
GBP 20,622,331
6 Authorise Issuance of Equity or For For Management
Equity-Linked Securities without
Pre-emptive Rights Pursuant to the Terms
of Any Share Schemes and Otherwise up to
Aggregate Nominal Amount of GBP 3,093,349
7 Authorise Market Purchase of Ordinary For For Management
Shares up to GBP 6,186,699
- --------------------------------------------------------------------------------
SMITH & NEPHEW PLC
Ticker: SNN Security ID: GB0009223206
Meeting Date: MAY 6, 2004 Meeting Type: Annual
Record Date:
# Proposal Mgt Rec Vote Cast Sponsor
1 Accept Financial Statements and Statutory For For Management
Reports
2 Approve Final Dividend of 3.1 Pence Per For For Management
Share
3 Re-elect Warren Knowlton as Director For For Management
4 Re-elect Christopher O'Donnell as For For Management
Director
5 Re-elect Richard De Schutter as Director For For Management
6 Re-elect Rolf Stomberg as Director For For Management
7 Re-appoint Ernst and Young LLP as For For Management
Auditors and Authorise Board to Fix
Remuneration of Auditors
8 Authorise Issuance of Equity or For For Management
Equity-Linked Securities with Pre-emptive
Rights up to Aggregate Nominal Amount of
GBP 33,321,078
9 Approve Remuneration Report For For Management
10 Approve the Smith and Nephew 2004 For For Management
Performance Share Plan
11 Approve the Smith and Nephew 2004 For For Management
Executive Share Option Plan
12 Approve the Smith and Nephew 2004 For For Management
Co-investment Plan
13 Authorise the Directors to Establish For For Management
Overseas Share Schemes
14 Authorise the Directors to Establish the For For Management
New Discretionary Trust
15 Amend the Smith and Nephew 2001 UK For For Management
Approved Share Option Plan
16 Amend the Smith and Nephew 2001 UK For For Management
Unapproved Share Option Plan
17 Approve Reclassification of the One For For Management
Issued 'B' Ordinary Share of 12 2/9 Pence
as an Ordinary Share Having the Same
Rights and Subject to the Same
Restrictions as Existing Ordinary Shares
18 Authorise 93,486,408 Shares for Market For For Management
Purchase
19 Adopt New Articles of Association For For Management
20 Authorise Issuance of Equity or For For Management
Equity-Linked Securities without
Pre-emptive Rights up to Aggregate
Nominal Amount of GBP 5,713,057
21 Approve Increase in Remuneration of For For Management
Non-Executive Directors to GBP 900,000
Per Year
- --------------------------------------------------------------------------------
ST. JUDE MEDICAL, INC.
Ticker: STJ Security ID: 790849103
Meeting Date: MAY 12, 2004 Meeting Type: Annual
Record Date: MAR 15, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Michael A. Rocca For For Management
1.2 Elect Director David A. Thompson For For Management
1.3 Elect Director Stefan K. Widensohler For For Management
2 Ratify Auditors For For Management
3 Approve Executive Incentive Bonus Plan For For Management
4 Increase Authorized Common Stock For For Management
5 Limit Executive Compensation Against Against Shareholder
- --------------------------------------------------------------------------------
SUN PHARMACEUTICAL INDUS. LTD.
Ticker: Security ID: INE044A01028
Meeting Date: JUL 31, 2004 Meeting Type: Extraordinary Shareholders
Record Date:
# Proposal Mgt Rec Vote Cast Sponsor
1 Approve Merger Agreement with Phlox For Against Management
Pharmaceuticals Ltd.
2 Issue Shares in Connection with Merger For Against Management
- --------------------------------------------------------------------------------
SUN PHARMACEUTICAL INDUS. LTD.
Ticker: Security ID: INE044A01028
Meeting Date: MAY 6, 2004 Meeting Type: Special
Record Date:
# Proposal Mgt Rec Vote Cast Sponsor
1 Approve Issuance of Equity or For Against Management
Equity-Linked Securities without
Preemptive Rights
2 Approve Increase in Borrowing Powers For Against Management
3 Approve Investment in Another Company For For Management
4 Approve Merger Agreement with Hindustan For For Management
Antibiotics Ltd.
5 Issue Shares in Connection with Merger For For Management
6 Appoint A. Dani as Director For For Management
7 Authorize Capitalization of Reserves for For For Management
Bonus Issue
- --------------------------------------------------------------------------------
TEVA PHARMACEUTICAL INDUSTRIES
Ticker: TEVA Security ID: 881624209
Meeting Date: OCT 27, 2003 Meeting Type: Special
Record Date: SEP 18, 2003
# Proposal Mgt Rec Vote Cast Sponsor
1 Elect G. Shalev as an External Director For For Management
2 Approve Increase in Remuneration of For For Management
Directors other than the Chairman
- --------------------------------------------------------------------------------
UCB
Ticker: Security ID: BE0003739530
Meeting Date: JUN 8, 2004 Meeting Type: Annual
Record Date:
# Proposal Mgt Rec Vote Cast Sponsor
1 Receive Directors' Report None Did Not Management
Vote
2 Receive Auditors' Report None Did Not Management
Vote
3 Approve Financial Statements and For Did Not Management
Allocation of Income Vote
4 Approve Discharge of Directors For Did Not Management
Vote
5 Approve Discharge of Auditors For Did Not Management
Vote
6 Reelect M. Eyskens and Prince Laurent as For Did Not Management
Independent Directors; Elect Frederik Vote
Rock Doliveux as Director; Reelect Daniel
Goosens as Auditor; Approve Remuneration
of Auditors of EUR 129,000 for the UCB
Group, of Which EUR 60,000 for UCB S.A.
- --------------------------------------------------------------------------------
WOCKHARDT LTD
Ticker: Security ID: INE049B01017
Meeting Date: APR 22, 2004 Meeting Type: Annual
Record Date:
# Proposal Mgt Rec Vote Cast Sponsor
1 Accept Financial Statements and Statutory For For Management
Reports
2 Approve Dividends of INR 6.5 Per Share For For Management
3 Reappoint B. Patel as Director For For Management
4 Appoint A. Mehta as Director For For Management
5 Approve S.R. Batliboi as Auditors and For For Management
Authorize Board to Fix Their Remuneration
6 Approve Voluntary Delisting of Company For For Management
Shares
7 Approve 2-for-1 Stock Split For For Management
8 Amend Articles of Association Re: 2-for-1 For For Management
Stock Split
9 Authorize Capitalization of Reserves for For For Management
Bonus Issue
- --------------------------------------------------------------------------------
ZIMMER HOLDINGS INC
Ticker: ZMH Security ID: 98956P102
Meeting Date: MAY 10, 2004 Meeting Type: Annual
Record Date: MAR 15, 2004
# Proposal Mgt Rec Vote Cast Sponsor
1.1 Elect Director Larry C. Glasscock For Did Not Management
Vote
1.2 Elect Director John L. McGoldrick For Did Not Management
Vote
2 Submit Shareholder Rights Plan (Poison Against Did Not Shareholder
Pill) to Shareholder Vote Vote
3 Ratify Auditors Against Did Not Shareholder
Vote
Pursuant to the requirements of the Investment Company Act of 1940,
the registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.
Merrill Lynch Healthcare Fund, Inc.
By: /s/ Terry K. Glenn
Terry K. Glenn,
President of Merrill Lynch Healthcare Fund, Inc.
Date: August 13, 2004